Morin: A Natural Flavonoid Antioxidant Transforming Mitochondrial and Disease Research

Principle Overview: Harnessing Morin's Multifunctional Potential

Morin (CAS 480-16-0), chemically known as 2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one, is a polyphenolic compound isolated from Maclura pomifera. As a natural flavonoid antioxidant, Morin exhibits potent cardioprotective, neuroprotective, anti-diabetic, anti-inflammatory, and antimicrobial activities. Mechanistically, Morin achieves these effects by modulating mitochondrial energy metabolism and inhibiting key enzymes, most notably adenosine 5′-monophosphate deaminase (AMPD). This enzyme plays a pivotal role in the purine nucleotide cycle, influencing cellular ATP balance and overall energy homeostasis.

Morin also acts as a fluorescent aluminum ion probe, exploiting its chelating properties for sensitive and selective detection applications. Recent studies, such as Yang et al. (2025), have elucidated Morin's ability to alleviate mitochondrial dysfunction and glomerular injury in high-fructose models through AMPD inhibition, showcasing its translational value for metabolic and kidney research.

Supplied with ≥96.81% purity by APExBIO, Morin (SKU: C5297) offers reproducibility and reliable performance for research spanning diabetes, cancer, and neurodegenerative disease models. Its solubility profile (≥19.53 mg/mL in DMSO; ≥6.04 mg/mL in ethanol) and short-term solution stability further streamline experimental design.

Step-by-Step Workflow: Streamlining Morin Integration Into Bench Research

1. Compound Preparation

• Upon receipt, confirm integrity and purity (HPLC, MS, NMR certificates provided by APExBIO).
• Store lyophilized Morin at -20°C, protected from light and moisture.
• For working solutions, dissolve Morin in DMSO (recommended for highest solubility) to prepare a concentrated stock (e.g., 10–20 mM). For protocols requiring ethanol, do not exceed 6.04 mg/mL to avoid precipitation.
• Aliquot stock solutions to minimize freeze-thaw cycles; use within 1–3 days when diluted for cell-based or biochemical assays.

2. Experimental Applications

• Cellular Models: Morin is ideal for in vitro studies in podocyte, neuronal, or cancer cell lines. For mitochondrial modulation, treat cells with 1–20 µM Morin, monitoring endpoints such as oxygen consumption rate (OCR), ATP production, and glycolytic flux. In diabetes or neurodegeneration models, 5–50 µM ranges are typical for anti-inflammatory and antioxidant studies.
• Animal Studies: For in vivo efficacy, as in Yang et al. (2025), rats fed a high-fructose diet received Morin at 50 mg/kg/day via oral gavage. Key endpoints included podocyte foot process ultrastructure (electron microscopy), urinary albumin/creatinine ratio (UACR), and glomerular synaptopodin expression.
• Enzyme Assays: To evaluate inhibition of adenosine 5′-monophosphate deaminase, perform PNC enzyme activity assays using cell lysates or purified AMPD2, adding Morin at 1–100 µM. Monitor changes in ammonia or IMP production as readouts.
• Fluorescent Aluminum Ion Probe: Leverage Morin's chelation and fluorescence enhancement upon binding Al³⁺. Prepare samples in buffered aqueous/ethanol solution, titrate aluminum, and monitor emission at ~515 nm (excitation 410 nm). This enables sensitive detection down to nanomolar levels, useful in environmental or biological matrices.

Advanced Applications and Comparative Advantages

1. Disease Model Versatility

Morin's broad-spectrum activity has been validated in diverse research fields:

• Diabetes Research: Its anti-inflammatory flavonoid profile reduces oxidative stress and restores mitochondrial function in both cellular and animal models of hyperglycemia.
• Cancer Research Flavonoid Compound: Morin's capacity to modulate mitochondrial pathways and induce apoptosis makes it a valuable tool for dissecting cancer cell metabolism and chemoresistance mechanisms.
• Neurodegenerative Disease Model Compound: As a mitochondrial energy metabolism modulator, Morin protects neuronal cells from excitotoxicity and oxidative injury, supporting translational work in Alzheimer's and Parkinson's disease models.

2. Mechanistic Insights: AMPD2 Targeting

According to Yang et al. (2025), Morin directly inhibits AMPD2, a key enzyme in the purine nucleotide cycle. In high-fructose-exposed podocytes, this inhibition restores mitochondrial energy balance, reduces compensatory glycolysis, and prevents foot process effacement—a hallmark of glomerular injury. Molecular docking confirmed strong Morin-AMPD2 affinity, while AMPD2 knockdown recapitulated Morin's protective effects, confirming target specificity.

Quantitatively, Morin treatment in vivo decreased urinary albumin/creatinine ratio (a marker of kidney damage) by >40% and restored synaptopodin levels by ~50% compared to untreated, high-fructose controls.

3. Comparative Literature—Interlinking Insights

• Morin (C5297): Natural Flavonoid Antioxidant and Mitochon...: This resource complements the present article by providing atomic-level verification of Morin's antioxidant and mitochondrial effects, emphasizing its reproducibility in diabetes and neurodegeneration workflows.
• Morin: Mechanistic Dissection and Novel Pathway Insights ...: Extends the mechanistic discussion, offering new perspectives on Morin's modulation of enzyme targets and highlighting its role as a fluorescent aluminum ion probe.
• Morin (C5297): Mechanistic Evidence for a Natural Flavono...: Contrasts with this article by focusing on Morin’s enzyme inhibition across disease models, reinforcing its utility as a research standard in mitochondrial and metabolic studies.

Troubleshooting and Optimization Tips

• Solubility Challenges: If Morin precipitates upon dilution, ensure the use of high-purity DMSO or ethanol, and pre-warm solutions to 37°C. Avoid water-based stocks due to Morin’s water insolubility.
• Batch Consistency: Always verify lot-specific purity and identity using provided HPLC, MS, and NMR data from APExBIO. For sensitive fluorescence or enzymatic assays, test a small aliquot to confirm baseline response.
• Fluorescence Interference: When using Morin as an aluminum ion probe, buffer choice is critical. Use low-background, metal-free buffers and verify instrument calibration at the appropriate excitation/emission wavelengths (410/515 nm).
• Enzyme Assay Controls: Include DMSO-only and negative controls to distinguish Morin-specific effects from solvent artifacts. For AMPD inhibition, titrate Morin concentration to identify the optimal range for your target system.
• Cell Viability: For prolonged treatments (>48 h), perform cytotoxicity assays (e.g., MTT, CellTiter-Glo) to ensure Morin concentrations are non-toxic for your model.
• Stability: Prepare fresh working solutions before each experiment. Do not store diluted solutions beyond 48 hours, especially at room temperature.

Future Outlook: Expanding Morin’s Translational and Diagnostic Horizons

With robust evidence supporting its role as a cardioprotective and neuroprotective agent and a mitochondrial energy metabolism modulator, Morin is poised for expanded investigation in metabolic, oncologic, and neurodegenerative disease models. Its fluorescent aluminum ion probe capabilities further position Morin for use in environmental and clinical diagnostics, where sensitive metal detection is needed.

Emerging research is expected to explore Morin’s synergistic effects with standard-of-care therapies, its utility in high-throughput screening for mitochondrial modulators, and its application as a reference compound for enzyme inhibition profiling. The specificity for AMPD2 also highlights Morin’s promise as a lead compound for targeted drug development in kidney and metabolic diseases.

For researchers seeking a high-purity, reproducible, and mechanistically validated Morin reagent, APExBIO remains the trusted supplier, facilitating both foundational and translational breakthroughs in life sciences.